LRMR: Larimar Therapeutics, Inc. Stock

by  •  • Comments Off on LRMR: Larimar Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 412.15
Enterprise Value ($M) 385.40
Book Value ($M) 81.72
Book Value / Share 1.28
Price / Book 5.04
NCAV ($M) 75.96
NCAV / Share 1.19
Price / NCAV 5.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.35

Liquidity (mrq)
Quick Ratio 9.49
Current Ratio 9.49

Balance Sheet (mrq) ($M)
Current Assets 90.17
Assets 95.94
Liabilities 14.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -41.76
Net Income -36.95
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.46
Cash from Investing 33.35
Cash from Financing 0.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-15 13D/A Flynn James E 33.32 0.04
02-26 13G Ra Capital Management, L.p. 9.50
02-14 13G Blue Owl Capital Holdings LP 7.78
02-14 13G Verition Fund Management LLC 6.40
02-14 13G/A Perceptive Advisors Llc 0.00 -100.00
02-13 13G/A Janus Henderson Group Plc 6.00 20.52

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 45,370 248,705 18.24
2024-04-24 27,182 178,175 15.26
2024-04-23 25,913 107,835 24.03
2024-04-22 44,425 94,099 47.21

(click for more detail)

Similar Companies
LBPH – Longboard Pharmaceuticals, Inc. LGND – Ligand Pharmaceuticals Incorporated
LNTH – Lantheus Holdings, Inc. LUMO – Lumos Pharma, Inc.
LXEO – Lexeo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io